Section Arrow
Quote
LYCA.NASDAQ
- Lycia Therapeutics Inc.
Quotes are at least 15-min delayed:2026/10/27 08:21 EDT
Pre Market
Last
 27
-1.85 (-6.41%)
Bid
--
Ask
28.8
High 27.12 
Low 25 
Volume 49 
Regular Hours (Closed)
Last
 28.85
-1.15 (-3.83%)
Day High 
30.905 
Prev. Close
30 
1-M High
36.4931 
Volume 
965.72K 
Bid
--
Ask
28.8
Day Low
23.73 
Open
23.73 
1-M Low
22.19 
Market Cap 
-- 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA -- 
20-SMA -- 
50-SMA -- 
52-W High 36.4931 
52-W Low 22.19 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.58/--
Enterprise Value
1.73M
Balance Sheet
Book Value Per Share
-2.54
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
--
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
AZTRAzitra1.53+0.815+113.99%3.58PE
Pre Market 1.3 -0.23 -15.03%
SNTISenti Biosciences Holdings Inc.0.1751-0.0133-7.06%-- 
Pre Market 0.1798 +0.0047 +2.68%
SPRCSciSparc Ltd.1.29+0.2+18.35%0PE
Pre Market 0.8251 -0.4649 -36.04%
VBIOValion Bio Inc.0.84-0.1-10.64%-- 
Pre Market 0.7482 -0.0918 -10.93%
MRNAModerna198.85-1.25-0.62%-- 
Pre Market 192.7 -6.15 -3.09%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Lycia Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory and allergic diseases.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.